|Dosage Form||Capsule (oral; 25 mg)|
|Drug Class||Kinase inhibitors|
- To treat newly diagnosed acute myeloid leukemia that is FLT3 mutation-positive in adults.
- To treat aggressive systemic mastocytosis in adults.
- To treat systemic mastocytosis with associated hematological neoplasm in adults.
- To treat mast cell leukemia in adults.